2017 Q4 Form 10-K Financial Statement
#000114420418033269 Filed on June 07, 2018
Income Statement
| Concept | 2017 Q4 | 2017 Q1 | 2017 |
|---|---|---|---|
| Revenue | $74.00K | $2.717M | $59.00K |
| YoY Change | -98.03% | 1112.95% | -98.68% |
| Cost Of Revenue | $0.00 | $130.0K | $128.0K |
| YoY Change | -100.0% | 30.0% | -71.62% |
| Gross Profit | $70.00K | $2.590M | $2.838M |
| YoY Change | -98.07% | 2058.33% | -29.28% |
| Gross Profit Margin | 94.59% | 95.33% | 4810.17% |
| Selling, General & Admin | $920.0K | $1.296M | $4.342M |
| YoY Change | -17.86% | -42.3% | -33.36% |
| % of Gross Profit | 1314.29% | 50.04% | 153.0% |
| Research & Development | $910.0K | $711.0K | $3.721M |
| YoY Change | 18.18% | -29.88% | -7.62% |
| % of Gross Profit | 1300.0% | 27.45% | 131.11% |
| Depreciation & Amortization | $70.00K | $80.00K | $100.0K |
| YoY Change | -22.22% | 135.29% | 0.0% |
| % of Gross Profit | 100.0% | 3.09% | 3.52% |
| Operating Expenses | $1.830M | $2.007M | $8.063M |
| YoY Change | -3.68% | -38.44% | -23.53% |
| Operating Profit | -$1.754M | $582.0K | -$5.200M |
| YoY Change | -201.45% | -118.55% | -20.7% |
| Interest Expense | -$120.0K | $177.0K | -$592.0K |
| YoY Change | -40.0% | -28.92% | -166.29% |
| % of Operating Profit | 30.41% | ||
| Other Income/Expense, Net | $0.00 | -$177.0K | $0.00 |
| YoY Change | -28.05% | -100.0% | |
| Pretax Income | -$1.870M | $405.0K | -$5.817M |
| YoY Change | -222.22% | -111.97% | -21.26% |
| Income Tax | -$26.74M | $0.00 | -$135.0K |
| % Of Pretax Income | 0.0% | ||
| Net Earnings | -$1.738M | $405.0K | -$5.682M |
| YoY Change | -213.3% | -111.97% | -23.09% |
| Net Earnings / Revenue | -2348.65% | 14.91% | -9630.51% |
| Basic Earnings Per Share | -$0.08 | $0.03 | |
| Diluted Earnings Per Share | -$0.08 | $0.03 | -$357.3K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 11.91M shares | ||
| Diluted Shares Outstanding | 12.08M shares | 15.90M shares |
Balance Sheet
| Concept | 2017 Q4 | 2017 Q1 | 2017 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $2.220M | $3.840M | $2.220M |
| YoY Change | -17.2% | -65.0% | -17.2% |
| Cash & Equivalents | $2.220M | $3.843M | $2.220M |
| Short-Term Investments | |||
| Other Short-Term Assets | $280.0K | $2.800M | $275.0K |
| YoY Change | -89.89% | 833.33% | -90.07% |
| Inventory | $0.00 | $0.00 | $0.00 |
| Prepaid Expenses | |||
| Receivables | $0.00 | $40.00K | $0.00 |
| Other Receivables | $70.00K | $50.00K | $71.00K |
| Total Short-Term Assets | $2.566M | $6.738M | $2.566M |
| YoY Change | -56.58% | -42.06% | -56.58% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $679.0K | $739.0K | $679.0K |
| YoY Change | -21.68% | -28.25% | -21.68% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | |||
| YoY Change | |||
| Total Long-Term Assets | $2.038M | $2.118M | $2.038M |
| YoY Change | -11.31% | -24.09% | -11.31% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $2.566M | $6.738M | $2.566M |
| Total Long-Term Assets | $2.038M | $2.118M | $2.038M |
| Total Assets | $4.604M | $8.856M | $4.604M |
| YoY Change | -43.91% | -38.59% | -43.91% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $3.000K | $209.0K | $3.000K |
| YoY Change | -96.1% | -45.0% | -96.1% |
| Accrued Expenses | $939.0K | $1.040M | $1.639M |
| YoY Change | 33.57% | -14.05% | 133.14% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $2.694M | $2.798M | $2.694M |
| YoY Change | 13.38% | 8.66% | 13.38% |
| Total Short-Term Liabilities | $4.631M | $4.403M | $4.631M |
| YoY Change | 32.81% | -0.61% | 32.81% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $2.142M | $0.00 |
| YoY Change | -100.0% | -55.47% | -100.0% |
| Other Long-Term Liabilities | $0.00 | $600.0K | $0.00 |
| YoY Change | -100.0% | 39.53% | -100.0% |
| Total Long-Term Liabilities | $0.00 | $2.142M | $0.00 |
| YoY Change | -100.0% | -59.12% | -100.0% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $4.631M | $4.403M | $4.631M |
| Total Long-Term Liabilities | $0.00 | $2.142M | $0.00 |
| Total Liabilities | $4.631M | $7.143M | $4.631M |
| YoY Change | -34.08% | -26.13% | -34.08% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$380.4M | -$374.3M | |
| YoY Change | 1.52% | ||
| Common Stock | $380.4M | $376.0M | |
| YoY Change | 1.19% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$27.00K | $1.713M | -$27.00K |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $4.604M | $8.856M | $4.604M |
| YoY Change | -43.91% | -38.59% | -43.91% |
Cashflow Statement
| Concept | 2017 Q4 | 2017 Q1 | 2017 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.738M | $405.0K | -$5.682M |
| YoY Change | -213.3% | -111.97% | -23.09% |
| Depreciation, Depletion And Amortization | $70.00K | $80.00K | $100.0K |
| YoY Change | -22.22% | 135.29% | 0.0% |
| Cash From Operating Activities | -$1.620M | $1.298M | -$4.510M |
| YoY Change | -191.01% | -167.6% | -18.93% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | -100.0% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | $310.0K | $309.0K |
| YoY Change | -90.25% | -97.16% | |
| Cash From Investing Activities | $0.00 | $309.0K | $309.0K |
| YoY Change | -90.13% | -97.14% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $4.000M | ||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -950.0K | -$445.0K | $1.240M |
| YoY Change | 9.2% | 8.54% | -148.84% |
| NET CHANGE | |||
| Cash From Operating Activities | -1.620M | $1.298M | -$4.510M |
| Cash From Investing Activities | 0.000 | $309.0K | $309.0K |
| Cash From Financing Activities | -950.0K | -$445.0K | $1.240M |
| Net Change In Cash | -2.570M | $1.162M | -$2.961M |
| YoY Change | -382.42% | 45.25% | -209.83% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$1.620M | $1.298M | -$4.510M |
| Capital Expenditures | $0.00 | $0.00 | $0.00 |
| Free Cash Flow | -$1.620M | $1.298M | -$4.510M |
| YoY Change | -190.5% | -165.92% | -20.01% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2016 | us-gaap |
Interest Paid Net
InterestPaidNet
|
576000 | USD |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2485000 | USD |
| CY2017 | acur |
Operating Loss Carryforwards Expiration Term
OperatingLossCarryforwardsExpirationTerm
|
P20Y | |
| CY2017 | acur |
Operating Loss Carry Forwards Expiration Year
OperatingLossCarryForwardsExpirationYear
|
2037 | |
| CY2017Q4 | us-gaap |
Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
|
150000 | USD |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
| CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3536000 | shares |
| CY2016 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
36000 | shares |
| CY2017 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
| CY2016 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
| CY2017 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
| CY2016 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
| CY2017 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2017 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2017 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2017 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | |
| CY2017Q2 | dei |
Entity Public Float
EntityPublicFloat
|
4200000 | USD |
| CY2017 | dei |
Trading Symbol
TradingSymbol
|
ACUR | |
| CY2018Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
21033528 | shares |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
679000 | USD |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
867000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1224000 | USD |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1431000 | USD |
| CY2017Q4 | us-gaap |
Assets
Assets
|
4604000 | USD |
| CY2016Q4 | us-gaap |
Assets
Assets
|
8208000 | USD |
| CY2016Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
77000 | USD |
| CY2016Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
703000 | USD |
| CY2016Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
27000 | USD |
| CY2017Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2694000 | USD |
| CY2016Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2376000 | USD |
| CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
4631000 | USD |
| CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
208000 | USD |
| CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
380145000 | USD |
| CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-380380000 | USD |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-27000 | USD |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1183000 | USD |
| CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4604000 | USD |
| CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8208000 | USD |
| CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3487000 | USD |
| CY2017Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
0 | USD |
| CY2016Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
2979000 | USD |
| CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2681000 | USD |
| CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2220000 | USD |
| CY2017Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
0 | USD |
| CY2016Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
23000 | USD |
| CY2017Q4 | acur |
Collaboration Revenue Receivable
CollaborationRevenueReceivable
|
0 | USD |
| CY2016Q4 | acur |
Collaboration Revenue Receivable
CollaborationRevenueReceivable
|
79000 | USD |
| CY2017Q4 | acur |
Royalty Receivable
RoyaltyReceivable
|
71000 | USD |
| CY2016Q4 | acur |
Royalty Receivable
RoyaltyReceivable
|
50000 | USD |
| CY2016 | acur |
Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
|
451000 | USD |
| CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3721000 | USD |
| CY2017 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4342000 | USD |
| CY2016 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
11870000 | shares |
| CY2017 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15903000 | shares |
| CY2016 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11870000 | shares |
| CY2017 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
59000 | USD |
| CY2016 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
392000 | USD |
| CY2017 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
8191000 | USD |
| CY2016 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
11021000 | USD |
| CY2017 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | USD |
| CY2016 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2000 | USD |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7900000 | USD |
| CY2016 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
65000 | USD |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
588000 | USD |
| CY2016 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
18000 | USD |
| CY2017 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
8000 | USD |
| CY2017 | acur |
Issuance Of Common Stock Value Under Market Offerings
IssuanceOfCommonStockValueUnderMarketOfferings
|
4000000 | USD |
| CY2017 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
87000 | USD |
| CY2016 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
138000 | USD |
| CY2017 | acur |
Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
|
0 | USD |
| CY2016 | acur |
Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
|
26000 | USD |
| CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
464000 | USD |
| CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
588000 | USD |
| CY2017 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
99000 | USD |
| CY2016 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
145000 | USD |
| CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1457000 | shares |
| CY2017 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
4000000 | USD |
| CY2017 | acur |
Amortization Of Bond Premium In Marketable Securities
AmortizationOfBondPremiumInMarketableSecurities
|
0 | USD |
| CY2016 | acur |
Amortization Of Bond Premium In Marketable Securities
AmortizationOfBondPremiumInMarketableSecurities
|
31000 | USD |
| CY2017 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
207000 | USD |
| CY2016 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
207000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
|
0 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
|
-37000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-103000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
59000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
7000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-149000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
| CY2016 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-175000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-74000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-33000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
236000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
139000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
141000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
172000 | USD |
| CY2017 | us-gaap |
Proceeds From Other Equity
ProceedsFromOtherEquity
|
0 | USD |
| CY2016 | us-gaap |
Proceeds From Other Equity
ProceedsFromOtherEquity
|
1000 | USD |
| CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-2961000 | USD |
| CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2696000 | USD |
| CY2017 | acur |
Provision For Sales Returns
ProvisionForSalesReturns
|
49000 | USD |
| CY2016 | acur |
Provision For Sales Returns
ProvisionForSalesReturns
|
99000 | USD |
| CY2017 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
0 | USD |
| CY2016 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
10873000 | USD |
| CY2017 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
103000 | USD |
| CY2016 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | USD |
| CY2017 | acur |
Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
|
206000 | USD |
| CY2016 | acur |
Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
|
0 | USD |
| CY2017 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
2760000 | USD |
| CY2016 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
2540000 | USD |
| CY2017 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
0 | USD |
| CY2016 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
2000 | USD |
| CY2017 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
2000 | USD |
| CY2016 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-1000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-23000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-19000 | USD |
| CY2017 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
| CY2016 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
| CY2017 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD |
| CY2016 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
82000 | USD |
| CY2016 | acur |
Increase Decrease In Collaboration Revenue Receivable
IncreaseDecreaseInCollaborationRevenueReceivable
|
43000 | USD |
| CY2017 | acur |
Increase Decrease In Royalty Receivable
IncreaseDecreaseInRoyaltyReceivable
|
21000 | USD |
| CY2016 | acur |
Increase Decrease In Royalty Receivable
IncreaseDecreaseInRoyaltyReceivable
|
45000 | USD |
| CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
611000 | USD |
| CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
498000 | USD |
| CY2016Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
243000 | USD |
| CY2016Q4 | us-gaap |
Inventory Gross
InventoryGross
|
341000 | USD |
| CY2016Q4 | us-gaap |
Inventory Net
InventoryNet
|
309000 | USD |
| CY2016Q4 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
98000 | USD |
| CY2016Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
32000 | USD |
| CY2015Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
70000 | USD |
| CY2017Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
0 | USD |
| CY2017 | acur |
Inventory Valuation Written Off Finished Goods
InventoryValuationWrittenOffFinishedGoods
|
32000 | USD |
| CY2016 | acur |
Inventory Valuation Written Off Finished Goods
InventoryValuationWrittenOffFinishedGoods
|
64000 | USD |
| CY2017 | acur |
Inventory Reserve Expense Finished Goods
InventoryReserveExpenseFinishedGoods
|
0 | USD |
| CY2016 | acur |
Inventory Reserve Expense Finished Goods
InventoryReserveExpenseFinishedGoods
|
26000 | USD |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1833000 | USD |
| CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1858000 | USD |
| CY2017 | us-gaap |
Depreciation
Depreciation
|
100000 | USD |
| CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
70000 | USD |
| CY2016Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
116000 | USD |
| CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
149000 | USD |
| CY2016Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
232000 | USD |
| CY2017Q4 | acur |
Other Accrued Taxes Current
OtherAccruedTaxesCurrent
|
14000 | USD |
| CY2016Q4 | acur |
Other Accrued Taxes Current
OtherAccruedTaxesCurrent
|
1000 | USD |
| CY2017Q4 | us-gaap |
Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
|
16000 | USD |
| CY2016Q4 | us-gaap |
Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
|
16000 | USD |
| CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
36000 | USD |
| CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
47000 | USD |
| CY2017Q4 | acur |
Marketing Advertising And Promotion
MarketingAdvertisingAndPromotion
|
0 | USD |
| CY2016Q4 | acur |
Marketing Advertising And Promotion
MarketingAdvertisingAndPromotion
|
10000 | USD |
| CY2013Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
10000000 | USD |
| CY2013Q4 | acur |
Debt Default Long Term Debt Percentage
DebtDefaultLongTermDebtPercentage
|
0.1335 | pure |
| CY2017 | us-gaap |
Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
|
260000 | USD |
| CY2017 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2018-12-01 | |
| CY2015Q1 | acur |
Debt Instrument Cash Maintenance
DebtInstrumentCashMaintenance
|
2500000 | USD |
| CY2016Q4 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
6000000 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Fee Amount
DebtInstrumentFeeAmount
|
50000 | USD |
| CY2017 | acur |
Debt Consulting Placement Fee
DebtConsultingPlacementFee
|
100000 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.1016 | pure |
| CY2017 | us-gaap |
Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
|
2760000 | USD |
| CY2017 | acur |
Debt Instrument Classification Amount
DebtInstrumentClassificationAmount
|
0 | USD |
| CY2016Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
5500000 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
2740000 | USD |
| CY2017 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
66000 | USD |
| CY2016Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
98000 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
32000 | USD |
| CY2017 | acur |
Classification Of Debt Discount Premium
ClassificationOfDebtDiscountPremium
|
0 | USD |
| CY2016Q4 | acur |
Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
|
-47000 | USD |
| CY2017 | acur |
Amortization Expense Of Debt Instrument Issuance Costs
AmortizationExpenseOfDebtInstrumentIssuanceCosts
|
33000 | USD |
| CY2017Q4 | acur |
Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
|
-14000 | USD |
| CY2017Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
2694000 | USD |
| CY2017 | acur |
Classification Of Deferred Debt Issuance Costs
ClassificationOfDeferredDebtIssuanceCosts
|
0 | USD |
| CY2017 | acur |
Interest Expense Debt Discount
InterestExpenseDebtDiscount
|
66000 | USD |
| CY2016 | acur |
Interest Expense Debt Discount
InterestExpenseDebtDiscount
|
95000 | USD |
| CY2017 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
33000 | USD |
| CY2016 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
50000 | USD |
| CY2017 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
497000 | USD |
| CY2016 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
748000 | USD |
| CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
75000 | USD |
| CY2016Q4 | us-gaap |
Revenues
Revenues
|
3765000 | USD |
| CY2016Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
3362000 | USD |
| CY2017 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-1978000 | USD |
| CY2016 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-2512000 | USD |
| CY2016 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-254000 | USD |
| CY2017 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-203000 | USD |
| CY2017 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
116000 | USD |
| CY2016 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
159000 | USD |
| CY2017 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
-3000 | USD |
| CY2016 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
2000 | USD |
| CY2017 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-24570000 | USD |
| CY2016 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
2556000 | USD |
| CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-135000 | USD |
| CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2017Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
167700000 | USD |
| CY2017 | us-gaap |
State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
|
1000000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
1028000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
47192000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
1276000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
2135000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
66000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
57000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
203000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
332000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3804000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
51036000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3804000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
51036000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2016Q1 | us-gaap |
Revenues
Revenues
|
224000 | USD |
| CY2016Q2 | us-gaap |
Revenues
Revenues
|
257000 | USD |
| CY2016Q3 | us-gaap |
Revenues
Revenues
|
218000 | USD |
| CY2016Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
3336000 | USD |
| CY2016Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2287000 | USD |
| CY2016Q4 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2036000 | USD |
| CY2016Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3138000 | USD |
| CY2016Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3079000 | USD |
| CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2069000 | USD |
| CY2016Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1729000 | USD |
| CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3384000 | USD |
| CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3288000 | USD |
| CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2250000 | USD |
| CY2016Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1534000 | USD |
| CY2016Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.28 | |
| CY2016Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.28 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.19 | |
| CY2016Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.13 | |
| CY2016Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.28 | |
| CY2016Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.28 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.19 | |
| CY2016Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.13 | |
| CY2017Q1 | us-gaap |
Revenues
Revenues
|
2717000 | USD |
| CY2017 | acur |
Increase Decrease In Sales Return Liability
IncreaseDecreaseInSalesReturnLiability
|
99000 | USD |
| CY2016 | acur |
Increase Decrease In Sales Return Liability
IncreaseDecreaseInSalesReturnLiability
|
0 | USD |
| CY2017Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
100000 | USD |
| CY2017Q3 | acur |
Number Of Common Stock Need To Hold To Designate As Director
NumberOfCommonStockNeedToHoldToDesignateAsDirector
|
600000 | shares |
| CY2017Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
0 | USD |
| CY2016Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
2500000 | USD |
| CY2017Q4 | us-gaap |
Inventory Net
InventoryNet
|
0 | USD |
| CY2017Q4 | us-gaap |
Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
|
135000 | USD |
| CY2016Q4 | us-gaap |
Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
|
0 | USD |
| CY2017Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
700000 | USD |
| CY2016Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
0 | USD |
| CY2017 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD |
| CY2016 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
26000 | USD |
| CY2017 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
4000 | USD |
| CY2016 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
60000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
135000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
0 | USD |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | USD |
| CY2017 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4000000 | USD |
| CY2017Q2 | us-gaap |
Revenues
Revenues
|
92000 | USD |
| CY2017Q3 | us-gaap |
Revenues
Revenues
|
83000 | USD |
| CY2017Q4 | us-gaap |
Revenues
Revenues
|
74000 | USD |
| CY2017Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2135000 | USD |
| CY2017Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2083000 | USD |
| CY2017Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2145000 | USD |
| CY2017Q4 | acur |
Cash Cash Equivalent And Marketable Securities
CashCashEquivalentAndMarketableSecurities
|
2200000 | USD |
| CY2017Q4 | acur |
Working Capital
WorkingCapital
|
2100000 | USD |
| CY2017Q4 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
1828000 | USD |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
582000 | USD |
| CY2017Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1991000 | USD |
| CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2062000 | USD |
| CY2017Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1754000 | USD |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.18 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.12 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.08 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.18 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.12 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.08 | |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
405000 | USD |
| CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2149000 | USD |
| CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2200000 | USD |
| CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1738000 | USD |
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
0 | USD |
| CY2016Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
7000 | USD |
| CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
11834000 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20796000 | shares |
| CY2017 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><i>Reclassifications</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Certain reclassifications have been made to the prior year’s amounts to conform to the current year's presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 0.2in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><i>Use of Estimates</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Management is required to make certain estimates and assumptions in order to prepare consolidated financial statements in conformity with GAAP. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Management periodically evaluates estimates used in the preparation of the consolidated financial statements for continued reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based on such periodic evaluations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><i>Concentration of Credit Risk</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Financial instruments that potentially subject the Company to a significant concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains deposits in federally insured financial institutions which are in excess of federally insured limits. However, management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
-105000 | USD |
| CY2017 | acur |
Effective Income Tax Rate Reconciliation Tax Credit Federal Research Amount
EffectiveIncomeTaxRateReconciliationTaxCreditFederalResearchAmount
|
70000 | USD |
| CY2016 | acur |
Effective Income Tax Rate Reconciliation Tax Credit Federal Research Amount
EffectiveIncomeTaxRateReconciliationTaxCreditFederalResearchAmount
|
0 | USD |
| CY2017 | acur |
Effective Income Tax Rate Reconciliation Tax Credit Federal Alternative Minimum Tax Amount
EffectiveIncomeTaxRateReconciliationTaxCreditFederalAlternativeMinimumTaxAmount
|
135000 | USD |
| CY2016 | acur |
Effective Income Tax Rate Reconciliation Tax Credit Federal Alternative Minimum Tax Amount
EffectiveIncomeTaxRateReconciliationTaxCreditFederalAlternativeMinimumTaxAmount
|
0 | USD |
| CY2017 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
26603000 | USD |
| CY2016 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
0 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1231000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1161000 | USD |
| CY2017Q4 | acur |
Deferred Tax Assets State Research Tax Credit Carryforwards
DeferredTaxAssetsStateResearchTaxCreditCarryforwards
|
0 | USD |
| CY2016Q4 | acur |
Deferred Tax Assets State Research Tax Credit Carryforwards
DeferredTaxAssetsStateResearchTaxCreditCarryforwards
|
159000 | USD |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2512000 | USD |
| CY2017Q1 | acur |
License Agreement Option Products Description
LicenseAgreementOptionProductsDescription
|
In addition, MainPointe has the option to add to the MainPointe Agreement certain additional products, or Option Products, containing PSE and utilizing the Impede technology for a fee of $500 thousand per product (for all product strengths). Such Option Products include the product candidate Loratadine with pseudoephedrine. If the territory has been expanded prior to the exercise of a product option, the option fee will be increased to $750 thousand per product. If the territory is expanded after the payment of the $500 thousand product option fee, a one-time $250 thousand fee will be due for each product. If a third party is interested in developing or licensing rights to an Option Product, MainPointe must exercise its option for that product or its option rights for such product will terminate. | |
| CY2017 | acur |
Agreement Termination Notice Description
AgreementTerminationNoticeDescription
|
Egalet may terminate the Egalet Agreement for convenience on 120 days prior written notice, which termination may not occur prior to the second anniversary of Egalets launch of Oxaydo. Termination does not affect a partys rights accrued prior thereto, but there are no stated payments in connection with termination other than payments of obligations previously accrued. For all terminations (but not expiration), the Egalet Agreement provides for the transition of development and marketing of Oxaydo from Egalet to us, including the conveyance by Egalet to us of the trademarks and all regulatory filings and approvals relating to Oxaydo, and for Egalets supply of Oxaydo for a transition period. | |
| CY2017Q4 | acur |
Accrued Cost Sharing Expenses Clinical Studies
AccruedCostSharingExpensesClinicalStudies
|
328000 | USD |
| CY2016Q4 | acur |
Accrued Cost Sharing Expenses Clinical Studies
AccruedCostSharingExpensesClinicalStudies
|
150000 | USD |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2807000 | USD |
| CY2017Q4 | acur |
Impairment Of Property Plant And Equipment Reserve
ImpairmentOfPropertyPlantAndEquipmentReserve
|
0 | USD |
| CY2016Q4 | acur |
Impairment Of Property Plant And Equipment Reserve
ImpairmentOfPropertyPlantAndEquipmentReserve
|
-82000 | USD |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
| CY2016 | us-gaap |
Depreciation
Depreciation
|
100000 | USD |
| CY2017Q4 | acur |
Accrued Cost Sharing Expenses
AccruedCostSharingExpenses
|
328000 | USD |
| CY2016Q4 | acur |
Accrued Cost Sharing Expenses
AccruedCostSharingExpenses
|
150000 | USD |
| CY2017Q4 | acur |
Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
|
326000 | USD |
| CY2016Q4 | acur |
Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
|
131000 | USD |
| CY2017 | acur |
Inventory Reserve Expense
InventoryReserveExpense
|
32000 | USD |
| CY2016 | acur |
Inventory Reserve Expense
InventoryReserveExpense
|
96000 | USD |
| CY2013Q4 | us-gaap |
Secured Debt
SecuredDebt
|
10000000 | USD |
| CY2017Q3 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
4000000 | USD |
| CY2017 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
15790000 | shares |
| CY2016 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
11834000 | shares |
| CY2017 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
113000 | shares |
| CY2016 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2017Q4 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
82000 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4510000 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5563000 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
309000 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
10798000 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1240000 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2539000 | USD |
| CY2017 | us-gaap |
Interest Paid Net
InterestPaidNet
|
355000 | USD |
